Servier Bio-innovation Llc

This study is testing whether adding a new drug called S095029 to an existing cancer immunotherapy (pembrolizumab) is safe and can help control advanced stomach or esophageal cancers that have a specific genetic feature (MSI-H/dMMR). It will involve about 48 people whose cancer h…

This study is testing three new experimental immunotherapy drugs, each combined with an existing immunotherapy called cemiplimab, for adults with advanced non-small cell lung cancer who haven't had prior treatment. The goal is to see if these combinations are safe and can help co…